5 ÷ 2 = 2.5 mg/mL. Concentration is vial content divided by diluent volume, so 5 mg of peptide in 2 mL of bacteriostatic water gives 2.5 mg/mL. On a U-100 barrel one unit is 0.01 mL, so one unit of this solution carries 0.025 mg — 25 µg. That is the number to write on the label, because you will not reconstruct it from memory at an awkward moment.
In practice, reconstitution is the step where most hands-on errors enter the system, which is why spending time on technique here pays off more than anywhere else.
If the material arrived warm and it was lyophilised, test it and proceed on the result.
Dead space by syringe type
| Configuration | Dead volume | Loss at 5 mg/mL | Over 20 draws |
|---|
| Fixed-needle insulin syringe | 3–5 µL | 15–25 µg | 0.3–0.5 mg |
| Low-dead-space, detachable | <2 µL | <10 µg | <0.2 mg |
| Standard luer-lock + 30G | 35–60 µL | 175–300 µg | 3.5–6 mg |
| Luer-lock + 21G drawing needle | 70–100 µL | 350–500 µg | 7–10 mg |
On re-freezing something that thawed in transit: if it arrived as a lyophilised solid that warmed but never got wet, re-freezing costs you nothing except the thermal cycle.
Published data on syringe dead space in the context of injection-equipment programmes quantifies low-dead-space designs as retaining under 2 µL against 35 µL or more.
I would flag the obvious failure mode: people get the concentration right, get the volume right, and then read the syringe against the wrong scale.
Do the arithmetic twice, ideally with someone else doing it independently.
6The dead-space number surprised me until I did the multiplication across twenty draws. – birk_nordahl 2 months ago 7Thank you — the worked example is what makes this usable. – t_oyelaran 4 months ago add a comment